Senti Biosciences Inc (SNTI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $5.38M
Last updated: Nov 17, 2026 at 11:06 AM ET
Senti Biosciences Inc (SNTI) Earnings: Report Dates and Results
Senti Biosciences (SNTI) is expected to report earnings on Mar 22, 2027. In the quarter ended Jun 30, 2026, Senti Biosciences reported EPS of -$0.41, below the -$0.33 estimate. It beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
SNTI has an expected report date of Mar 22, 2027.
Earnings History
Of the 13 quarters below that had an estimate, SNTI beat 6 and missed 7. The widest gap in the table came in the quarter ended Mar 31, 2025, when EPS landed 151.79% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$0.41 | -$0.33 | -$0.33 - -$0.20 | -24.24% | Miss | N/A | 2 | 0 up, 0 down | Aug 14, 2026 | $17000 |
| Mar 31, 2026 | -$0.14 | -$0.36 | -$0.42 - -$0.27 | +61.11% | Beat | N/A | 3 | 0 up, 0 down | May 14, 2026 | $16000 |
| Dec 31, 2025 | -$0.53 | -$0.47 | -$0.63 - -$0.22 | -11.98% | Miss | N/A | 3 | 0 up, 1 down | Mar 27, 2026 | $22000 |
| Sep 30, 2025 | -$0.69 | -$0.57 | -$0.59 - -$0.55 | -21.05% | Miss | N/A | 3 | 0 up, 0 down | Nov 13, 2025 | N/A |
| Jun 30, 2025 | -$0.56 | -$0.55 | -$1.25 - -$0.55 | -1.82% | Miss | N/A | 2 | 0 up, 0 down | Aug 7, 2025 | N/A |
| Mar 31, 2025 | -$1.41 | -$0.56 | N/A | -151.79% | Miss | N/A | N/A | N/A | May 6, 2025 | N/A |
| Dec 31, 2024 | -$0.67 | -$3.13 | N/A | +78.59% | Beat | N/A | N/A | N/A | Mar 20, 2025 | $5.86M |
| Sep 30, 2024 | -$6.31 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2024 | N/A |
| Jun 30, 2024 | -$2.45 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 13, 2024 | N/A |
| Mar 31, 2024 | -$0.27 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | May 9, 2024 | N/A |
| Dec 31, 2023 | -$0.42 | -$0.23 | N/A | -82.22% | Miss | N/A | N/A | 0 up, 0 down | Mar 21, 2024 | $333000 |
| Sep 30, 2023 | -$2.46 | -$4.28 | -$4.70 - -$4.20 | +42.52% | Beat | N/A | 3 | 0 up, 0 down | Nov 13, 2023 | $338000 |
| Jun 30, 2023 | -$4.20 | -$4.64 | -$5.00 - -$4.60 | +9.48% | Beat | N/A | 3 | 0 up, 0 down | Aug 11, 2023 | $937000 |
| Mar 31, 2023 | -$4.20 | -$3.90 | -$5.20 - -$3.50 | -7.69% | Miss | N/A | 3 | 0 up, 0 down | May 9, 2023 | $1.29M |
| Dec 31, 2022 | -$0.42 | -$0.44 | -$0.51 - -$0.35 | +4.55% | Beat | N/A | 4 | 0 up, 0 down | Mar 22, 2023 | $58000 |
| Sep 30, 2022 | -$3.80 | -$4.15 | -$5.40 - -$3.30 | +8.43% | Beat | N/A | 3 | 0 up, 0 down | Nov 10, 2022 | $1.77M |
| Jun 30, 2022 | -$0.57 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 9, 2022 | $1.36M |
| Mar 31, 2022 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 16, 2022 | $1.10M |
| Dec 31, 2021 | -$0.11 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 7, 2022 | $793000 |
| Sep 30, 2021 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 10, 2021 | $1.10M |
| Jun 30, 2021 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 2, 2021 | $793000 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$3.19, after -$9.69 the year before. It was -$0.13 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$3.19 | N/A |
| Dec 31, 2024 | -$9.69 | N/A |
| Dec 31, 2023 | -$11.28 | N/A |
| Dec 31, 2022 | -$4.83 | N/A |
| Dec 31, 2021 | -$0.13 | N/A |
Frequently Asked Questions About SNTI
When is Senti Biosciences's next earnings date?
Senti Biosciences's next earnings report is expected for Mar 22, 2027.
Did SNTI beat earnings estimates last quarter?
No. Senti Biosciences reported EPS of -$0.41 for the quarter ended Jun 30, 2026, below the -$0.33 estimate by 24.24%.
What EPS do analysts expect from SNTI next quarter?
The consensus EPS estimate for Senti Biosciences for the quarter ending Dec 31, 2026 is -$0.33 from 4 analysts, with estimates from -$0.43 to -$0.22.
How often does SNTI beat earnings estimates?
Senti Biosciences beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate, with an average surprise of -19.17%.
SNTI pages: Overview, Earnings, Forecast, Financials, Competitors